Interestingly, the administration of anti-ADAM8 treatment to pre-existing tumors followed by a maintenance treatment for a duration of 5 weeks after tumor resection on day 15 exhibited a remarkable reduction in the metastatic capacity. This evidence concerns the gene ADAM8 and neoplasm.